Predictive Approaches in Drug Discovery and Development
Editat de J Andrew Williams, Richard Lalonde, Jeffrey R Koup, David D Christ, Sean Ekinsen Limba Engleză Hardback – 10 apr 2012
Preț: 900.64 lei
Preț vechi: 989.72 lei
-9% Nou
Puncte Express: 1351
Preț estimativ în valută:
159.37€ • 186.88$ • 139.96£
159.37€ • 186.88$ • 139.96£
Carte tipărită la comandă
Livrare economică 03-17 februarie 26
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780470170830
ISBN-10: 0470170832
Pagini: 416
Dimensiuni: 161 x 240 x 26 mm
Greutate: 0.78 kg
Editura: Wiley
Locul publicării:Hoboken, United States
ISBN-10: 0470170832
Pagini: 416
Dimensiuni: 161 x 240 x 26 mm
Greutate: 0.78 kg
Editura: Wiley
Locul publicării:Hoboken, United States
Public țintă
Pharmaceutical scientists pursing drug research and development, including management, bench–level pharmacologists, and toxicologists; Clinical pharmacologists and clinicians, ADME/Tox and pharmaceutical scientists and students; Pharmaceutical companies interested in improving decision making and reducing costs; Regulatory agencies like the US FDA and EPA, British MHRA, and other European and Japanese equivalents.Notă biografică
J. Andrew Williams, PHD, is Director of Translational Oncology at Pfizer Oncology. Richard Lalonde, PharmD, is Vice President and Global Head of Clinical Pharmacology at Pfizer. Jeffrey Koup, PharmD, is a consultant for PKPD modeling and the owner of Lakeside PKPD, LLC. David D. Christ, PHD, is a consultant with SNC Partners LLC.
Descriere
Practical Utility of Biomarkers in Drug Discovery and Development covers all aspects of biomarker research applied to drug discovery and development and contains state-of-the-art appraisals on the practical utility of genomic, biochemical, and protein biomarkers.